Clinical Trial Update: Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a completed Phase 2 study evaluating amifostine in pediatric patients with newly diagnosed de novo myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | Phase 2 | Status: COMPLETED